Intrauterine adhesions treated with hysteroscopic adhesiolysis and subsequent obstetric outcome: A retrospective matched cohort study
- PMID: 38418403
- DOI: 10.1111/1471-0528.17793
Intrauterine adhesions treated with hysteroscopic adhesiolysis and subsequent obstetric outcome: A retrospective matched cohort study
Abstract
Objective: To examine whether a history of hysteroscopic adhesiolysis (HA)-treated intrauterine adhesions (IUAs) was associated with an increased risk of adverse obstetrical outcomes in subsequent pregnancies.
Design: Retrospective cohort study.
Setting: A tertiary-care hospital in Shanghai, China.
Population: A cohort of 114 142 pregnant women who were issued an antenatal card and received routine antenatal care in Shanghai First Maternity and Infant Hospital, between January 2016 and October 2021.
Methods: From the cohort of 114 142 pregnant women, each woman with a history of HA-treated IUA prior to the current pregnancy (n = 780) was matched with four women without a history of IUAs (n = 3010) using propensity score matching. The matching variables were maternal age and parity, mode of conception, pre-pregnancy body mass index and prior history of abortion.
Main outcome measures: Pregnancy complications, placental abnormalities, postpartum haemorrhage and adverse birth outcomes.
Results: Compared with women with no history of IUAs, women with a history of HA-treated IUAs were at higher risk of pre-eclampsia (RR 1.69, 95% CI 1.23-2.33), placenta accreta spectrum (RR 4.72, 95% CI 3.9-5.73), placenta praevia (RR 4.23, 95% CI 2.85-6.30), postpartum haemorrhage (RR 2.86, 95% CI 1.94-4.23), preterm premature rupture of membranes (RR 3.02, 95% CI 1.97-4.64) and iatrogenic preterm birth (RR 2.86, 95% CI 2.14-3.81). Those women were also more likely to receive cervical cerclage (RR 5.63, 95% CI 3.95-8.02) during pregnancy and haemostatic therapies after delivery (RR 2.17, 95% CI 1.75-2.69). Moreover, we observed that the RRs of those adverse obstetrical outcomes increased with the increasing number of hysteroscopic surgeries.
Conclusions: This study found that a history of HA-treated IUAs, especially a history of repeated HAs, was associated with an increased risk of adverse obstetrical outcomes.
Keywords: cohort study; hysteroscopic adhesiolysis; obstetrical outcomes; propensity score matching.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
The density of endometrial glandular openings: a novel variable to predict the live birth rate in patients with intrauterine adhesions following hysteroscopic adhesiolysis.Hum Reprod. 2021 Mar 18;36(4):965-975. doi: 10.1093/humrep/deaa377. Hum Reprod. 2021. PMID: 33486509 Free PMC article.
-
Effectiveness of Hyaluronic Acid Gel and Intrauterine Devices in Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis in Infertile Women.J Minim Invasive Gynecol. 2022 Feb;29(2):284-290. doi: 10.1016/j.jmig.2021.08.010. Epub 2021 Aug 22. J Minim Invasive Gynecol. 2022. PMID: 34433103
-
Treatment of intrauterine adhesions and subsequent pregnancy outcomes in an in vitro fertilization population.Am J Obstet Gynecol. 2024 Nov;231(5):536.e1-536.e10. doi: 10.1016/j.ajog.2024.05.026. Epub 2024 May 20. Am J Obstet Gynecol. 2024. PMID: 38777163
-
Reproductive outcomes in women with mild intrauterine adhesions; a systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2022 Dec;35(25):6933-6941. doi: 10.1080/14767058.2021.1931103. Epub 2021 May 27. J Matern Fetal Neonatal Med. 2022. PMID: 34044740
-
Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.Cochrane Database Syst Rev. 2018 Dec 5;12(12):CD009461. doi: 10.1002/14651858.CD009461.pub4. Cochrane Database Syst Rev. 2018. PMID: 30521679 Free PMC article.
Cited by
-
Short-term reproductive outcomes analysis and prediction of the modified uterine stent treatment for mild to moderate intrauterine adhesions: experience at a single institution.BMC Womens Health. 2024 Apr 23;24(1):252. doi: 10.1186/s12905-024-03098-9. BMC Womens Health. 2024. PMID: 38654192 Free PMC article.
-
Risk of Placenta Accreta Spectrum Disorder After Prior Non-Cesarean Delivery Uterine Surgery: A Systematic Review and Meta-analysis.Obstet Gynecol. 2025 Jun 1;145(6):628-638. doi: 10.1097/AOG.0000000000005824. Epub 2025 Feb 6. Obstet Gynecol. 2025. PMID: 39913920 Free PMC article.
-
Enhancing exosome stability and delivery with natural polymers to prevent intrauterine adhesions and promote endometrial regeneration: a review.J Nanobiotechnology. 2025 Jul 21;23(1):529. doi: 10.1186/s12951-025-03603-8. J Nanobiotechnology. 2025. PMID: 40685359 Free PMC article. Review.
References
REFERENCES
-
- Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Brolmann HAM, et al. Systematic review and meta‐analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long‐term reproductive outcome. Hum Reprod Update. 2014;20(2):262–278.
-
- Johary J, Xue M, Zhu X, Xu D, Velu PP. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review. J Minim Invasive Gynecol. 2014;21(1):44–54.
-
- Bosteels J, Weyers S, Mol BW, D'Hooghe T. Anti‐adhesion barrier gels following operative hysteroscopy for treating female infertility: a systematic review and meta‐analysis. Gynecol Surg. 2014;11(2):113–127.
-
- Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555–569.
-
- Wallach EE, Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril. 1982;37(5):593–610.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical